These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 8415670)

  • 1. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
    Kaye KM; Izumi KM; Kieff E
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):9150-4. PubMed ID: 8415670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation.
    Izumi KM; Kaye KM; Kieff ED
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1447-52. PubMed ID: 9037073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues.
    Kaye KM; Izumi KM; Mosialos G; Kieff E
    J Virol; 1995 Feb; 69(2):675-83. PubMed ID: 7815530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro.
    Robertson ES; Tomkinson B; Kieff E
    J Virol; 1994 Mar; 68(3):1449-58. PubMed ID: 8107208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
    Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
    J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B.
    Longnecker R; Miller CL; Tomkinson B; Miao XQ; Kieff E
    J Virol; 1993 Aug; 67(8):5068-74. PubMed ID: 8392630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.
    Dirmeier U; Neuhierl B; Kilger E; Reisbach G; Sandberg ML; Hammerschmidt W
    Cancer Res; 2003 Jun; 63(11):2982-9. PubMed ID: 12782607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation.
    Izumi KM; Kaye KM; Kieff ED
    J Virol; 1994 Jul; 68(7):4369-76. PubMed ID: 8207810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense to Epstein Barr Virus-encoded LMP1 does not affect the transcription of viral and cellular proliferation-related genes, but induces phenotypic effects on EBV-transformed B lymphocytes.
    Masciarelli S; Mattioli B; Galletti R; Samoggia P; Chichiarelli S; Mearini G; Mattia E
    Oncogene; 2002 Jun; 21(26):4166-70. PubMed ID: 12037673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, expressed after transformation of primary human B lymphocytes by Epstein-Barr virus (EBV) is induced by the EBV oncogene LMP1.
    Mosialos G; Hanissian SH; Jawahar S; Vara L; Kieff E; Chatila TA
    J Virol; 1994 Mar; 68(3):1697-705. PubMed ID: 8107230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs.
    Robertson E; Kieff E
    J Virol; 1995 Feb; 69(2):983-93. PubMed ID: 7815566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential.
    Longnecker R; Miller CL; Miao XQ; Marchini A; Kieff E
    J Virol; 1992 Nov; 66(11):6461-9. PubMed ID: 1328675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
    Aguirre AJ; Robertson ES
    J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation.
    Kaye KM; Izumi KM; Li H; Johannsen E; Davidson D; Longnecker R; Kieff E
    J Virol; 1999 Dec; 73(12):10525-30. PubMed ID: 10559372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
    Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines.
    Higuchi M; Kieff E; Izumi KM
    J Virol; 2002 Jan; 76(1):455-9. PubMed ID: 11739714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1.
    Wang Q; Lingel A; Geiser V; Kwapnoski Z; Zhang L
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
    Peng M; Lundgren E
    Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.
    Tomkinson B; Robertson E; Kieff E
    J Virol; 1993 Apr; 67(4):2014-25. PubMed ID: 8445720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.
    Cahir McFarland ED; Izumi KM; Mosialos G
    Oncogene; 1999 Nov; 18(49):6959-64. PubMed ID: 10602470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.